How is Viking Therapeutics (VKTX) doing?

Viking Therapeutics is a company in the biotechnology industry, based in San Diego, CA, worth $3.3B. Here is how its shares and business compare with the rest of the market, and where it shows up on our dashboards.

Updated Oct 9, 2026

market beat

Weak

Viking Therapeutics shares are down 12% over the past year, 24 points behind the S&P 500. Among large US stocks and funds it ranks in the 22nd percentile on market beat and the 91st on staying power. It appears on 1 of our dashboards.

$28.51−12% in a yearWorth $3.3B

Financials, earnings and news on Stox ›

Past year

The past year

Price against the S&P 500, each set to $100 a year ago. Score is its weekly rank against the market. Select a tile for that score month by month.

VKTX against the S&P 500, past year

$100 a year ago. Viking Therapeutics −12%, the S&P 500 +16%.

VKTXS&P 500

How is it doing against its group?

Its group is Health care, 86 large US stocks and funds whose prices tend to move together. Tools, biotech and large-cap pharma — defensive growth.

VKTX, past year−12%68 of 86 in the group

Rest of the group+21%equal-weighted

S&P 500+16%past year

Viking Therapeutics is −12% over the past year, against +21% for the rest of the group and +16% for the S&P 500. It ranks 68th of 86 in Health care.

VKTXRest of the group

Best in the groupRVMD Revolution Medicines+297%ILMN Illumina+184%NTRA Natera+133%

Worst in the groupPODD Insulet−57%BSX Boston Scientific−56%RARE Ultragenyx−50%

Health care on Stox ›

How much does it move?

Its typical daily move, against its own past year, the market and other large stocks. Swings describe risk, not direction.

Busier than usual Viking Therapeutics typically moves 7.7% in a day, busier than usual for it, and it swings more than 94% of large US stocks.

Typical day7.7%about $2.20 a share

Its usual5.7%busier than usual, 1.4× its year’s average

Against the S&P 5005.1×the index’s typical day is 1.1%

Unusual day±15.5%twice its typical day

Deepest fall, past year−36%now 32% below its high

In the S&P’s down weeks218%of the index’s fall, three years; beta 1.5

Typical daily move (ATR)Its year’s average 5.70%

VKTX on our dashboards

Every question where Viking Therapeutics appears, in the order of the home page, with its reading and place in that table. Select a question to open it with VKTX highlighted. Select a column to sort.

Question	Reading	Place	Details
Which stocks are most shorted? Who’s buying and selling	97Heavily shorted	26 of 60	% of float 22.9% · Days to cover 2.2 · Since last report +2.9 pts

Go deeper on Stox

VKTX’s full profile: financial statements, earnings and analysts’ estimates, valuation against its sector, recent news with a summary, and its scores in detail.

Open VKTX on Stox ›Its group on Stox ›

How to read this page

How it’s measured. Scores from Stox rank the stock against about 1,200 S&P 500, Nasdaq-100 and Russell 1000 stocks and popular funds, where 100 is best; market beat and staying power use prices, business growth uses revenue, margins and cash flow. Readings on other dashboards come from this site’s pages.

Sources. Daily prices and company financial statements from Financial Modeling Prep; scores and co-movement groups from Stox.

Scores are percentiles: 80 means the stock ranks above 80% of the others on that measure. They describe the recent past and are not advice or a forecast.

Its type follows Stox Atlas: each of the four scores is split at 50. “Steady” means its rank has held, high or low, so it says nothing on its own about direction.

Its group is the cluster of large US stocks whose prices have moved together over five years, with the market’s own moves taken out. The typical daily move is the average true range over 14 days, a measure of how far the price travels in a day including overnight gaps.

For financial statements, earnings and news, see VKTX’s full profile on Stox.

This page is information, not investment advice. About our data and methods ›

Full profile on Stox ›Health care stocks ›